Relationship between metabolic syndrome and cardiovascular risk with quality of life in people living with HIV: an integrative review
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i5e-209249Keywords:
Metabolic syndrome, Heart disease risk factors, HIV, Quality of life, Cardiovascular riskAbstract
Introduction: With the advent of antiretrovirals, the life expectancy of people living with HIV (PLHIV) has increased, however, on the other hand, this population has developed more comorbidities, such as metabolic syndrome (MetS) and increased cardiovascular risk (CVR), which can impact quality of life (QoL). Objective: To analyze the relationship between QoL and CVR and MetS in PLHIV. Method: The study is an integrative review according to the guidelines of the Systematic Reviews and Meta-Analyses. The search for manuscripts was carried out in five databases, without time or language restrictions. The findings were exported to the Rayyan platform, where duplicates and articles with a central theme not related to the subject were excluded. Subsequently, the full article was read to verify its inclusion in the review. Results: Initially, 995 articles were exported to the Rayyan system, of which 981 were excluded for being duplicates, or after reading the titles or abstracts. Subsequently, 14 studies were evaluated in full by the researchers, of which none were included in the review, as they did not meet the eligibility criteria. Conclusion: The lack of studies that evaluated the relationship between QoL, MetS, and CVR in PLHIV does not allow direct inferences to be made. However, a decrease in QoL associated with comorbidities linked to MetS and CVR is postulated in PLHIV.
Downloads
References
Brasil. Ministério da Saúde. Boletim epidemiológico HIV/Aids. Brasília; 2022. Disponível em: https://www.gov.br/aids/pt-br/centrais-de-conteudo/boletins-epidemiologicos/2022/hiv-aids
Paula AA, Pires DF, Alves Filho A, Lemos KRV, Veloso VG, Grinsztejn B, et al. Mortality profiles among people living with HIV/AIDS: comparison between Rio de Janeiro and other federative units between 1999 and 2015. Rev Bras Epidemiol. 2020;23:e200017. doi: https://doi.org/10.1590/1980-549720200017
World Health Organization. World Health Statistics. Geneva, Switzerland; 2021. Disponível em: https://www.who.int/data/gho/publications/world-health-statistics
Aberg JA. Aging and HIV infection: focus on cardiovascular disease risk. Top Antivir Med. 2020;27(4):102-105. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162677/
Nguyen KA, Peer N, Mills EJ, Kengne AP. A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population. PloS One. 2016;11(3):e0150970. doi: https://doi.org/10.1371/journal.pone.0150970
Chatzinikolaou A, Tzikas S, Lavdaniti M. Assessment of quality of life in patients with cardiovascular disease using the SF-36, MacNew, and EQ-5D-5L questionnaires. Cureus. 2021;13(9):e17982. doi: https://doi.org/10.7759/cureus.17982
Furlaneto CJ, Goulart RMM, Carmona RDM. A influência da síndrome metabólica sobre a qualidade de vida de pacientes em São Caetano do Sul. Nutrire Rev Soc Bras Aliment Nutr. 2009;34(2):85-99. Disponível em: http://sban.org.br/publicacoes/236.pdf
Castelo Filho A, Abrão P. Alterações metabólicas do paciente infectado por HIV. Arq Bras Endocrinol Metab. 2007;51(1):5-7. doi: https://doi.org/10.1590/S0004-27302007000100003
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269. doi: https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Martins Neto C, Pires EMC, Brito CS, Beserra OLMG, Silva Junior JF, Mota JV, et al. Qualidade de vida no contexto de pacientes com hiv/aids: um estudo comparativo. Saúde e Pesqui. 2019;12(2):333-341. doi: https://doi.org/10.17765/2176-9206.2019v12n2p333-341
Oliveira JS, Lima FLA, Saldanha AAW. Qualidade de vida em pessoas com mais de 50 anos HIV+: um estudo comparativo com a população geral. DST. 2008;20(3-4):179-184. Disponível em: https://bjstd.org/revista/article/view/945
Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV AIDS. 2012;4:117-124. doi: https://doi.org/10.2147/HIV.S32321
Gakhar H, Kamali A, Holodniy M. Health-related quality of life assessment after antiretroviral therapy: a review of the literature. Drugs. 2013;73(7):651-672. doi: https://doi.org/10.1007/s40265-013-0040-4
Raimundo P, Miranda A, Ribeiro J, Mansinho |K. Risco cardiovascular em doentes com infecção por vírus da imunodeficiência humana. Acta Méd Port. 2010;23(4):669-676. doi: https://doi.org/10.20344/amp.688
Ko HY, Lee JK, Shin JY, Jo E. Health-related quality of life and cardiovascular disease risk in Korean adults. Korean journal of family medicine. Korean J Fam Med. 2015;36(6):349-56. doi: https://doi.org/10.4082/kjfm.2015.36.6.349
De Visser CL, Bilo HJ, Groenier KH, De Visser W, Jong Meyboom-de B. The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual Life Res. 2002;11(3):249-261. doi: https://doi.org/10.1023/A:1015287825660
Ford ES, Li C. Metabolic syndrome and health-related quality of life among US adults. Ann Epidemiol. 2008;18(3):165-171. doi: https://doi.org/10.1016/j.annepidem.2007.10.009
Saboya PP, Bodanese LC, Zimmermann PR, Gustavo AD, Assumpção CM, Londero F. Metabolic syndrome and quality of life: a systematic review. Rev Lat Am Enfermagem. 2016;24:e2848. https://doi.org/10.1590/1518-8345.1573.2848
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ítalo Inácio Pereira, Adrielly Katrine Tozetto Morais Muto, Ester Rosa de Brito, Marianne Lucena da Silva, Ludimila Paula Vaz Cardoso, Luiz Fernando Gouvêa-e-Silva
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
